
Shiki Fujino
Articles
-
Oct 9, 2024 |
mdpi.com | Norikatsu Miyoshi |Shiki Fujino |Kengo Haruna |Soichiro Minami
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Feb 28, 2024 |
iv.iiarjournals.org | Ryota Mori |Norikatsu Miyoshi |Shiki Fujino |Tsunekazu Mizushima
Key Words:Adipose derived stem cellanal sphincter injuryintestinal incontinenceARSdefecation functionIntestinal incontinence is a common condition defined as the uncontrolled passage of feces or gas for at least one month and has a negative impact on quality of life (1). Although the main causes of defecation problems have been age-related weakness of defecation-related muscle groups, the number of patients who develop the condition after surgery has increased.
-
Nov 23, 2023 |
nature.com | Shiki Fujino |Norikatsu Miyoshi |Jun Koseki |Tsunekazu Mizushima
AbstractCirculating tumor cells (CTCs) play an important role in metastasis and recurrence. However, which cells comprise the complex tumor lineages in recurrence and are key in metastasis are unknown in colorectal cancer (CRC). CRC with high expression of POU5F1 has a poor prognosis with a high incidence of liver metastatic recurrence.
-
Feb 6, 2023 |
nature.com | Shiki Fujino
AbstractApproximately 10% of patients with colorectal cancer with submucosal invasion have lymph node metastasis. Pathological risk factors for lymph node metastasis have varying sensitivities and specificities. To predict the risk of lymph node metastasis, the identification of new risk factors is vital. Tumor-infiltrating T cells have been reported to improve the prognosis of many solid tumors.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →